vs
Side-by-side financial comparison of HERC HOLDINGS INC (HRI) and Moderna (MRNA). Click either name above to swap in a different company.
HERC HOLDINGS INC is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.1× Moderna). HERC HOLDINGS INC runs the higher net margin — -2.1% vs -19.7%, a 17.6% gap on every dollar of revenue. On growth, HERC HOLDINGS INC posted the faster year-over-year revenue change (32.3% vs -45.4%). HERC HOLDINGS INC produced more free cash flow last quarter ($94.0M vs $-880.0M). Over the past eight quarters, HERC HOLDINGS INC's revenue compounded faster (1343.1% CAGR vs -45.0%).
Herc Holdings Inc. is a leading North American equipment rental service provider. It offers rental assets including heavy construction machinery, power tools, temporary power and climate control systems, serving clients across construction, industrial, events, infrastructure and government segments, with operations across the U.S. and Canada.
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
HRI vs MRNA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.0B |
| Net Profit | $-24.0M | $-200.0M |
| Gross Margin | — | 79.6% |
| Operating Margin | — | -25.6% |
| Net Margin | -2.1% | -19.7% |
| Revenue YoY | 32.3% | -45.4% |
| Net Profit YoY | -33.3% | -1638.5% |
| EPS (diluted) | $-0.72 | $-0.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.1B | — | ||
| Q4 25 | $30.1M | — | ||
| Q3 25 | $10.1M | $1.0B | ||
| Q2 25 | $6.3M | — | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $4.1M | $966.0M | ||
| Q3 24 | — | $1.9B | ||
| Q4 23 | $5.0M | $2.8B |
| Q1 26 | $-24.0M | — | ||
| Q4 25 | $-99.9M | — | ||
| Q3 25 | $-7.5M | $-200.0M | ||
| Q2 25 | $-10.8M | — | ||
| Q1 25 | $-14.1M | — | ||
| Q4 24 | $-10.3M | $-1.1B | ||
| Q3 24 | — | $13.0M | ||
| Q4 23 | $-14.1M | $217.0M |
| Q1 26 | — | — | ||
| Q4 25 | 42.3% | — | ||
| Q3 25 | 25.8% | 79.6% | ||
| Q2 25 | 53.1% | — | ||
| Q1 25 | 35.0% | — | ||
| Q4 24 | 21.4% | 23.5% | ||
| Q3 24 | — | 72.4% | ||
| Q4 23 | 34.8% | 67.0% |
| Q1 26 | — | — | ||
| Q4 25 | -77.4% | — | ||
| Q3 25 | -153.5% | -25.6% | ||
| Q2 25 | -147.4% | — | ||
| Q1 25 | -242.7% | — | ||
| Q4 24 | -206.3% | -129.0% | ||
| Q3 24 | — | -3.8% | ||
| Q4 23 | -254.9% | 0.2% |
| Q1 26 | -2.1% | — | ||
| Q4 25 | -331.7% | — | ||
| Q3 25 | -74.1% | -19.7% | ||
| Q2 25 | -171.4% | — | ||
| Q1 25 | -332.8% | — | ||
| Q4 24 | -250.3% | -115.9% | ||
| Q3 24 | — | 0.7% | ||
| Q4 23 | -285.0% | 7.7% |
| Q1 26 | $-0.72 | — | ||
| Q4 25 | $-0.36 | — | ||
| Q3 25 | $-0.03 | $-0.51 | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | $-0.15 | $-2.91 | ||
| Q3 24 | — | $0.03 | ||
| Q4 23 | $-0.25 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.0M | $1.1B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.9B | $9.3B |
| Total Assets | $13.6B | $12.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $43.0M | — | ||
| Q4 25 | $550.7M | — | ||
| Q3 25 | $432.8M | $1.1B | ||
| Q2 25 | $67.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $30.0M | $1.9B | ||
| Q3 24 | — | $1.6B | ||
| Q4 23 | — | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $300.0K | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — |
| Q1 26 | $1.9B | — | ||
| Q4 25 | $437.8M | — | ||
| Q3 25 | $486.1M | $9.3B | ||
| Q2 25 | $90.8M | — | ||
| Q1 25 | $26.1M | — | ||
| Q4 24 | $16.6M | $10.9B | ||
| Q3 24 | — | $11.9B | ||
| Q4 23 | $33.1M | $13.9B |
| Q1 26 | $13.6B | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $550.2M | $12.1B | ||
| Q2 25 | $152.0M | — | ||
| Q1 25 | $104.6M | — | ||
| Q4 24 | $109.6M | $14.1B | ||
| Q3 24 | — | $15.8B | ||
| Q4 23 | $92.2M | $18.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $277.0M | $-847.0M |
| Free Cash FlowOCF − Capex | $94.0M | $-880.0M |
| FCF MarginFCF / Revenue | 8.3% | -86.6% |
| Capex IntensityCapex / Revenue | 13.6% | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $60.1M | $-1.9B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $277.0M | — | ||
| Q4 25 | $-12.7M | — | ||
| Q3 25 | $-11.0M | $-847.0M | ||
| Q2 25 | $-8.4M | — | ||
| Q1 25 | $-6.7M | — | ||
| Q4 24 | $-8.1M | $825.0M | ||
| Q3 24 | — | $-1.6B | ||
| Q4 23 | $-5.9M | $622.0M |
| Q1 26 | $94.0M | — | ||
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $-11.1M | $-880.0M | ||
| Q2 25 | $-8.5M | — | ||
| Q1 25 | $-6.8M | — | ||
| Q4 24 | $-8.1M | $303.0M | ||
| Q3 24 | — | $-1.7B | ||
| Q4 23 | $-6.0M | $402.0M |
| Q1 26 | 8.3% | — | ||
| Q4 25 | -47.6% | — | ||
| Q3 25 | -110.2% | -86.6% | ||
| Q2 25 | -135.5% | — | ||
| Q1 25 | -160.8% | — | ||
| Q4 24 | -197.1% | 31.4% | ||
| Q3 24 | — | -92.2% | ||
| Q4 23 | -121.5% | 14.3% |
| Q1 26 | 13.6% | — | ||
| Q4 25 | 5.3% | — | ||
| Q3 25 | 1.7% | 3.2% | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 0.7% | 54.0% | ||
| Q3 24 | — | 8.1% | ||
| Q4 23 | 2.3% | 7.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -120.46× | ||
| Q4 23 | — | 2.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HRI
| Equipment rental | $981.0M | 86% |
| Sales of rental equipment | $138.0M | 12% |
| Sales of new equipment, parts and supplies | $13.0M | 1% |
| Service and other revenue | $7.0M | 1% |
MRNA
| COVID19 | $971.0M | 96% |
| Other Revenue | $20.0M | 2% |
| Grant | $14.0M | 1% |
| Collaboration Arrangement Including Arrangements With Affiliate | $7.0M | 1% |
| License And Royalty | $2.0M | 0% |
